Nath Bio-Genes (India) Ltd

NSE: NATHBIOGEN · BSE: 537291 · Food, Beverages & Tobacco · 17 announcements

Share price: ₹136.87
Market cap: ₹260.1 Cr
Revenue (annual): ₹445.1 Cr
Net profit (annual): ₹41.63 Cr
P/E (TTM): 7.1×Sector 28.6×
Promoter holding: 45.60%+0.00% QoQ
FII holding: 0.26%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 4 Other Announcement 3 Financial Results 3 Board Meeting Outcome 3 Annual General Meeting 2 ED Probe / Tax Survey 1 Board Meeting Date 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

6 Aug 2026 15:08 IST BSE

ED Probe / Tax Survey

Nath Bio-Genes (India) ED Probe / Tax Survey

SEBI has initiated a forensic audit of Nath Bio-Genes (India) Ltd for financial years 2020-21 to 2025-26. CNK & Associates LLP has been appointed as the forensic auditor.

Execution: FY 2020-21 to 2025-26

Read the filing ↗